Non-invasive prenatal testing (NIPT) can detect genetic material (DNA) from the placenta in a blood test from the mother and screen for chromosomal abnormalities in the developing baby.
Detection of fetal RHD gene fragments in the maternal blood to predict fetal RhD status and guide prophylactic anti-D treatment.
Genetic carrier screening tests for gene changes in parents that when inherited by their children, may cause severe or life-threatening genetic conditions. Expanded carrier screening tests for hundreds of inherited conditions.
Testing your DNA to determine how quickly or slowly you metabolise (break down) medications can help your doctor to prescribe you the best medication at the right dose.
Testing for inherited cancer genes that increase your risk of having breast and ovarian cancer. Useful in prognosis, medical management and directing therapy.
Testing for inherited cancer genes that increase your risk of having colorectal, endometrial and gastric cancer. Useful in prognosis, medical management and directing therapy.
Testing for inherited cancer genes that increase the risk of prostate and pancreatic cancer.
Comprehensive genetic testing panels designed to assess inherited cancer risk and support earlier detection and personalised management strategies.
Targeted genetic panels to help identify inherited genes that increase the risk of rare tumours, and help to guide more personalised care decisions.
Genetics is helping to uncover the inherited factors behind many heart conditions. Understanding these genetic risks allows for personalised care, early interventions, and more effective management of heart disease for patients and their families.
Testing solid tumours for specific genetic changes (somatic genetic testing) that can help determine prognosis and direct therapy.